|
|
|
| Effect of hysteroscopy combined with uterine artery embolization for terminating pregnancy of women with type II uterine scar pregnancy after cesarean section |
| Sanhe Hospital of Huiyang, Huizhou, Guangdong Province, 5162000 |
|
|
|
Abstract To analyze the effect of hysteroscopy combined with uterine artery embolization for terminating pregnancy of women with uterine scar pregnancy (USP) after type II cesarean section. Methods: The clinical data of 150 women with USP after type II cesarean section from July 2016 to December 2018 were retrospectively collected. These women were divided into observation group and control group. The women in the observation group were given hysteroscopy combined prophylactic uterine artery embolization and methotrexate, and the women in the control group were given hysteroscopy combined with methotrexate. The differences of operation related indexes, such as operation time, intraoperative bleeding volume, vaginal bleeding time, hospitalization time, total effective rate after treatment, serum human chorionic gonadotropinβ (β-hCG), and other biochemical indexes, incidence of adverse reactions and prognosis of women between the two groups were compared. Results: The operative time, hospital stay time, vaginal bleeding time, and the intraoperative blood loss of women in the observation group were 23.8±15.1min, 7.4±2.4d, 5.3±1.1d, and 67.9±7.5ml, respectively, which were significant less than those (37.9±18.6min, 11.4±2.5d, 6.2±2.0d, and 102.7±10.5ml, respectively) of women in the control group, but the total postoperative effective rate of women in the observation group was 90.6%, which was significant higher than that (72.2%) of women in the control group. The adverse reaction rate, the time of serumβ-hCG recovery to normal level, the time of menstruation recovery, and the proportion of CSP reoccurrence of women in the observation group were 5.2%, 29.7±3.1d, 38.0±12.3d, and 2.1%, respectively, which were significant less than those (14.8%, 31.3±3.1d, 44.4±12.6d, 16.7%, respectively) of women in the control group (all P＜0.05). Conclusion: Hysteroscopy combined with prophylactic uterine artery embolization for terminating pregnancy of women with CSP after type II cesarean section has good effective, which can increase surgical efficiency, reduce adverse reactions, contribute to postoperative recovery and improve prognosis.
|
|
|
|
|
|
|
|
|
